BCMA-TARGETED CAR-T CELL THERAPY FOR MULTIPLE MYELOMA | Patent Publication Number 20230277589

US 20230277589 A1
Patent Number-
Application Number18052349
Filled DateNov 3, 2022
Priority DateNov 4, 2021
Publication DateSep 7, 2023
Original AssigneeNanjing Legend Biotech Co. Ltd.
Johnson & Johnson
Current AssigneeJanssen Biotech Inc.
Inventor/ApplicantsXiaohu FAN
Kevin DEBRAGANCA
Enrique ZUDAIRE
Muhammad AKRAM
Dong GENG
Lida PACAUD
Helen VARSOS
Jordan SCHECTER
Tonia NESHEIWAT
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.